| Website | macuclear.com |
| Category | BioTech |
| Employees |
| TOTAL | $1M |
| FUNDING TOTAL | $1M |
| Venture Round, 1/12 | $1M |
MacuCLEAR Inc.™ is a specialty clinical-stage pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye. MacuCLEAR has an active IND for MC-1101 and has completed a novel and successful Phase Ib/POC human clinical trial.
